Avanos Medical Stock Forecast, Price & News

-0.01 (-0.03 %)
(As of 07/30/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume208,633 shs
Average Volume216,802 shs
Market Capitalization$1.82 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive AVNS News and Ratings via Email

Sign-up to receive the latest news and ratings for Avanos Medical and its competitors with MarketBeat's FREE daily newsletter.

Avanos Medical logo

About Avanos Medical

Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

2.11 out of 5 stars

Medical Sector

456th out of 2,220 stocks

Surgical Appliances & Supplies Industry

10th out of 41 stocks

Analyst Opinion: 3.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Avanos Medical (NYSE:AVNS) Frequently Asked Questions

Is Avanos Medical a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Avanos Medical stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AVNS, but not buy additional shares or sell existing shares.
View analyst ratings for Avanos Medical
or view top-rated stocks.

What stocks does MarketBeat like better than Avanos Medical?

Wall Street analysts have given Avanos Medical a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Avanos Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Avanos Medical?

Avanos Medical saw a increase in short interest in July. As of July 15th, there was short interest totaling 1,280,000 shares, an increase of 23.1% from the June 30th total of 1,040,000 shares. Based on an average daily volume of 459,300 shares, the short-interest ratio is currently 2.8 days. Currently, 2.7% of the company's shares are short sold.
View Avanos Medical's Short Interest

When is Avanos Medical's next earnings date?

Avanos Medical is scheduled to release its next quarterly earnings announcement on Tuesday, August 3rd 2021.
View our earnings forecast for Avanos Medical

How can I listen to Avanos Medical's earnings call?

Avanos Medical will be holding an earnings conference call on Tuesday, August 3rd at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 877-344-7529 with passcode "10158622".

How were Avanos Medical's earnings last quarter?

Avanos Medical, Inc. (NYSE:AVNS) posted its earnings results on Thursday, May, 6th. The company reported $0.23 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.18 by $0.05. The company earned $181 million during the quarter, compared to analyst estimates of $175.68 million. Avanos Medical had a negative net margin of 5.38% and a positive trailing twelve-month return on equity of 3.23%. The business's revenue was up .3% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.16 earnings per share.
View Avanos Medical's earnings history

How has Avanos Medical's stock price been impacted by COVID-19 (Coronavirus)?

Avanos Medical's stock was trading at $29.01 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AVNS shares have increased by 30.8% and is now trading at $37.94.
View which stocks have been most impacted by COVID-19

What guidance has Avanos Medical issued on next quarter's earnings?

Avanos Medical updated its FY 2021 earnings guidance on Friday, May, 28th. The company provided EPS guidance of 1.100-1.250 for the period, compared to the Thomson Reuters consensus estimate of $1.190. The company issued revenue guidance of $729.10 million-$743.39 million, compared to the consensus revenue estimate of $738.32 million.

What price target have analysts set for AVNS?

2 equities research analysts have issued 12 month price targets for Avanos Medical's shares. Their forecasts range from $45.00 to $55.00. On average, they expect Avanos Medical's share price to reach $50.00 in the next twelve months. This suggests a possible upside of 31.8% from the stock's current price.
View analysts' price targets for Avanos Medical
or view top-rated stocks among Wall Street analysts.

Who are Avanos Medical's key executives?

Avanos Medical's management team includes the following people:
  • Mr. Joseph F. Woody, CEO & Director (Age 55, Pay $2.47M)
  • Mr. Michael C. Greiner, Sr. VP & CFO (Age 48, Pay $1.31M)
  • Mr. Arjun Ranjan Sarker, Sr. VP of International (Age 55, Pay $680.98k)
  • Mr. David Edward Ball, Sr. VP of Global Supply Chain & Procurement (Age 62, Pay $697k)
  • Mr. William David Haydon, Sr. VP & GM of Pain Management (Age 54, Pay $337.36k)
  • Mr. Renato Negro, VP, Controller & Chief Accounting Officer
  • Mr. David Crawford, VP of FP&A and Investor Relations and Treasurer
  • Mr. S. Ross Mansbach, Sr. VP, Interim Gen. Counsel & Corp. Sec.
  • Ms. Michelle Scharfenberg, Sr. VP and Chief Ethics & Compliance Officer
  • Ms. Rhonda D. Gibby, Sr. VP & Chief HR Officer (Age 53)

What is Joseph F. Woody's approval rating as Avanos Medical's CEO?

32 employees have rated Avanos Medical CEO Joseph F. Woody on Glassdoor.com. Joseph F. Woody has an approval rating of 51% among Avanos Medical's employees. This puts Joseph F. Woody in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Avanos Medical's key competitors?

What other stocks do shareholders of Avanos Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly-Clark (KMB), CVS Health (CVS), Honeywell International (HON), Pfizer (PFE), The Procter & Gamble (PG), Johnson & Johnson (JNJ), Raytheon Technologies (RTX), AT&T (T), Abbott Laboratories (ABT) and Alibaba Group (BABA).

What is Avanos Medical's stock symbol?

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Who are Avanos Medical's major shareholders?

Avanos Medical's stock is owned by many different institutional and retail investors. Top institutional investors include Alliancebernstein L.P. (0.17%), Exchange Traded Concepts LLC (0.10%), State of Alaska Department of Revenue (0.07%), Oregon Public Employees Retirement Fund (0.06%) and North Star Asset Management Inc. (0.05%).
View institutional ownership trends for Avanos Medical

Which institutional investors are selling Avanos Medical stock?

AVNS stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P..
View insider buying and selling activity for Avanos Medical
or view top insider-selling stocks.

Which institutional investors are buying Avanos Medical stock?

AVNS stock was bought by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Oregon Public Employees Retirement Fund, Exchange Traded Concepts LLC, and North Star Asset Management Inc..
View insider buying and selling activity for Avanos Medical
or or view top insider-buying stocks.

How do I buy shares of Avanos Medical?

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avanos Medical's stock price today?

One share of AVNS stock can currently be purchased for approximately $37.94.

How much money does Avanos Medical make?

Avanos Medical has a market capitalization of $1.82 billion and generates $714.80 million in revenue each year. The company earns $-27,200,000.00 in net income (profit) each year or $0.79 on an earnings per share basis.

How many employees does Avanos Medical have?

Avanos Medical employs 5,380 workers across the globe.

What is Avanos Medical's official website?

The official website for Avanos Medical is avanos.com.

Where are Avanos Medical's headquarters?

Avanos Medical is headquartered at 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004.

How can I contact Avanos Medical?

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]

This page was last updated on 8/1/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.